<?xml version="1.0" encoding="iso-8859-1"?><!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en"><head><meta content="text/html; charset=iso-8859-1" http-equiv="Content-Type" /><title>Medicinal Products Act (Arzneimittelgesetz &#8211; AMG)</title><link href="../css/style.css" media="screen" rel="stylesheet" type="text/css" /><link href="../css/print.html" media="print" rel="stylesheet" type="text/css" /><link href="../css/jnhtml.html" rel="stylesheet" type="text/css" /><!--[if lt IE 7]>
<style type="text/css">@import url(/css/englisch_stgb_inhaltsverz_im_ie6.css);</style>
<![endif]--></head><body><a name="Seitenanfang"><!----></a><div id="fTop"><div id="fTop1"><!----></div><div id="fTop2"><!----></div></div><div id="fTopLogos"><a href="http://www.bmjv.bund.de/" target="_blank"><img align="left" border="0" height="104" src="https://www.gesetze-im-internet.de/img/lay/BfJ_2021_WebSVG_en_en.svg" usemap="#imgmap2018913165839" width="230" /><map id="imgmap2018913165839" name="imgmap2018913165839"><area alt="Logo Federal Ministry of Justice" coords="149,102,0,1" href="https://www.bmj.de/" shape="rect" target="_blank" title="Link to Federal Ministry of Justice, the page is displayed in a separate window." /><area alt="Logo Federal Office of Justice" coords="154,0,228,103" href="https://www.bundesjustizamt.de/" shape="rect" target="_blank" title="Link to Federal Office of Justice, the page is displayed in a separate window." /></map></a></div><div id="nav_12793"><ul><li><a accesskey="0" class="nav" href="https://www.gesetze-im-internet.de/index.html">Startseite</a></li><li><a accesskey="2" class="nav" href="https://www.gesetze-im-internet.de/aktuell.html">Gesetze / Verordnungen</a></li><li><a accesskey="3" class="nav" href="https://www.gesetze-im-internet.de/aktuDienst.html">Aktualitätendienst</a></li><li><a accesskey="9" class="nav" href="https://www.gesetze-im-internet.de/titelsuche.html">Titelsuche</a></li><li><a accesskey="4" class="nav" href="https://www.gesetze-im-internet.de/volltextsuche.html">Volltextsuche</a></li><li><a class="navHigh" href="https://www.gesetze-im-internet.de/Teilliste_translations.html">Translations</a></li><li><a accesskey="5" class="nav" href="https://www.gesetze-im-internet.de/hinweise.html">Hinweise</a></li></ul><ul><li id="grDarst"><a accesskey="7" class="nav" href="https://www.gesetze-im-internet.de/hilfe.html">Tastenkombinationen</a></li><li id="grDarst6"><a class="nav" href="https://justiz.de/onlinedienste/bundesundlandesrecht/index.php" target="_blank" title="Die Startseite dieses Angebotes wird in einem neuen Fenster geöffnet">Landesrecht</a></li><li id="grDarst2"><a class="nav" href="https://www.rechtsprechung-im-internet.de/" target="_blank" title="Die Startseite des Bürgerservice Rechtsprechung im Internet wird in einem eigenen Fenster geöffnet">Rechtsprechung im Internet</a></li><li id="grDarst3"><a class="nav" href="https://www.verwaltungsvorschriften-im-internet.de/" target="_blank" title="Die Startseite dieses Angebotes wird in einem neuen Fenster geöffnet">Verwaltungsvorschriften im Internet</a></li><li id="grDarst7"><a class="nav" href="https://n-lex.europa.eu/n-lex/" target="_blank" title="Die Startseite des Portals N-Lex wird in einem eigenen Fenster geöffnet.">N-Lex</a></li></ul></div><div id="level2"><div id="content_12793"><div id="container"><h1 class="headline">Medicinal Products Act<br />(Arzneimittelgesetz &#8211; AMG)</h1><h2 class="headline">Full text in format:   <a href="englisch_amg.html"><abbr>HTML</abbr></a>  <a href="englisch_amg-2.html" target="_blank" title="pdf will be shown in separate tab"><abbr title="pdf will be shown in separate tab">PDF</abbr></a>   <a href="https://www.gesetze-im-internet.de/amg_1976/index.html"><img alt="text in German" border="0" height="15px" src="../img/lay/deutsch.html" style="vertical-align:middle;" title="text in German" width="25px" /></a></h2><div id="paddingLR12"><p style="text-align: left; font-weight: normal"><a name="p0000"><!----></a>Übersetzung durch den Sprachendienst des Bundesministeriums für Gesundheit.</p><p style="text-align: left; font-weight: normal"><a name="p0001"><!----></a>Translation provided by the Language Service of the Federal Ministry of Health.</p><p style="text-align: left; font-weight: normal"><a name="p0002"><!----></a>Stand: Die Übersetzung berücksichtigt die Änderung(en) des Gesetzes durch Artikel 1 des Gesetzes vom 23. Oktober 2024 (BGBl. 2024 I Nr. 324)<br />Der Stand der deutschsprachigen Dokumentation kann aktueller sein. Vergleichen Sie dazu bitte <a href="https://www.gesetze-im-internet.de/amg_1976/BJNR024480976.html" title="Verweis auf die deutsche Version">http://www.gesetze-im-internet.de/amg_1976/BJNR024480976.html</a>.</p><p style="text-align: left; font-weight: normal"><a name="p0003"><!----></a>Version information: The translation includes the amendment(s) to the Act by Article 1 of the Act of 23 October 2024 (Federal Law Gazette 2024 I no. 324)<br />Translations may not be updated at the same time as the German legal provisions displayed on this website. To compare with the current status of the German version, see <a href="https://www.gesetze-im-internet.de/amg_1976/BJNR024480976.html" title="Link to German version">http://www.gesetze-im-internet.de/amg_1976/BJNR024480976.html</a>.</p><p style="text-align: left; font-weight: normal"><a name="p0004"><!----></a></p><p style="text-align: left; font-weight: normal"><a name="p0005"><!----></a>Translations of any materials into languages other than German are intended solely as a convenience to the non-German-reading public. If any questions arise related to the accuracy of the information contained in the translation, please refer to the German version of the document which is the official version of the document. Any discrepancies or differences created in the translation are not binding and have no legal effect for compliance or enforcement purposes.</p><p style="text-align: left; font-weight: normal"><a name="p0006"><!----></a></p><p style="text-align: left; font-weight: normal"><a name="p0007"><!----></a>Zur Nutzung dieser Übersetzung lesen Sie bitte den Hinweis unter <a href="https://www.gesetze-im-internet.de/Teilliste_translations.html">"Translations"</a>.</p><p style="text-align: left; font-weight: normal"><a name="p0008"><!----></a>For conditions governing use of this translation, please see the information provided under <a href="https://www.gesetze-im-internet.de/Teilliste_translations.html">"Translations"</a>.</p><p style="text-align: left; font-weight: normal"><a name="p0009"><!----></a></p><p style="text-align: left; font-weight: normal"><a name="p0010"><!----></a></p><table border="0" width="100%"><colgroup><col width="2%" /><col width="2%" /><col width="2%" /><col width="2%" /><col width="2%" /><col width="2%" /><col width="2%" /><col width="2%" /><col width="2%" /><col width="2%" /><col width="80%" /></colgroup><tr><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td colspan="11"><a name="gl_p0086"><!----></a><a href="englisch_amg.html#p0086"><strong>Division 1<br />Purpose of the Act and definition of terms, scope</strong></a></td></tr><tr><td colspan="11"><a name="gl_p0087"><!----></a><a href="englisch_amg.html#p0087">Section 1<span class="paratitel">Purpose of the Act</span></a></td></tr><tr><td colspan="11"><a name="gl_p0089"><!----></a><a href="englisch_amg.html#p0089">Section 2<span class="paratitel">The term &#8216;medicinal product&#8217;</span></a></td></tr><tr><td colspan="11"><a name="gl_p0107"><!----></a><a href="englisch_amg.html#p0107">Section 3<span class="paratitel">The term &#8216;substance&#8217;</span></a></td></tr><tr><td colspan="11"><a name="gl_p0113"><!----></a><a href="englisch_amg.html#p0113">Section 4<span class="paratitel">Definition of additional terms</span></a></td></tr><tr><td colspan="11"><a name="gl_p0166"><!----></a><a href="englisch_amg.html#p0166">Section 4a<span class="paratitel">Exceptions to the scope of this Act</span></a></td></tr><tr><td colspan="11"><a name="gl_p0168"><!----></a><a href="englisch_amg.html#p0168">Section 4b<span class="paratitel">Special provisions governing advanced therapy medicinal products</span></a></td></tr><tr><td colspan="11"><a name="gl_p0206"><!----></a><a href="englisch_amg.html#p0206">Section 4c<span class="paratitel">Indication-based registry for advanced therapy medicinal products</span></a></td></tr><tr><td colspan="11"><a name="gl_p0208"><!----></a><a href="englisch_amg.html#p0208"><strong>Division 2<br />Requirements on medicinal products</strong></a></td></tr><tr><td colspan="11"><a name="gl_p0209"><!----></a><a href="englisch_amg.html#p0209">Section 5<span class="paratitel">Prohibition of unsafe medicinal products</span></a></td></tr><tr><td colspan="11"><a name="gl_p0212"><!----></a><a href="englisch_amg.html#p0212">Section 6<span class="paratitel">Prohibitions to protect health, power to issue ordinances</span></a></td></tr><tr><td colspan="11"><a name="gl_p0217"><!----></a><a href="englisch_amg.html#p0217">Section 6a<span class="paratitel">(repealed)</span></a></td></tr><tr><td colspan="11"><a name="gl_p0218"><!----></a><a href="englisch_amg.html#p0218">Section 7<span class="paratitel">Radiopharmaceuticals and medicinal products treated with ionising radiation</span></a></td></tr><tr><td colspan="11"><a name="gl_p0221"><!----></a><a href="englisch_amg.html#p0221">Section 8<span class="paratitel">Prohibitions to prevent deception</span></a></td></tr><tr><td colspan="11"><a name="gl_p0231"><!----></a><a href="englisch_amg.html#p0231">Section 9<span class="paratitel">The party responsible for placing on the market</span></a></td></tr><tr><td colspan="11"><a name="gl_p0234"><!----></a><a href="englisch_amg.html#p0234">Section 10<span class="paratitel">Labelling</span></a></td></tr><tr><td colspan="11"><a name="gl_p0288"><!----></a><a href="englisch_amg.html#p0288">Section 10a<span class="paratitel">Labelling of investigational and auxiliary medicinal products for clinical trials</span></a></td></tr><tr><td colspan="11"><a name="gl_p0292"><!----></a><a href="englisch_amg.html#p0292">Section 11<span class="paratitel">Package leaflet</span></a></td></tr><tr><td colspan="11"><a name="gl_p0340"><!----></a><a href="englisch_amg.html#p0340">Section 11a<span class="paratitel">Expert information</span></a></td></tr><tr><td colspan="11"><a name="gl_p0382"><!----></a><a href="englisch_amg.html#p0382">Section 12<span class="paratitel">Empowerment in respect of labelling, package leaflet and package sizes</span></a></td></tr><tr><td colspan="11"><a name="gl_p0401"><!----></a><a href="englisch_amg.html#p0401"><strong>Division 3<br />Manufacture of medicinal products</strong></a></td></tr><tr><td colspan="11"><a name="gl_p0402"><!----></a><a href="englisch_amg.html#p0402">Section 13<span class="paratitel">Manufacturing authorisation</span></a></td></tr><tr><td colspan="11"><a name="gl_p0439"><!----></a><a href="englisch_amg.html#p0439">Section 14<span class="paratitel">Decision on the manufacturing authorisation</span></a></td></tr><tr><td colspan="11"><a name="gl_p0462"><!----></a><a href="englisch_amg.html#p0462">Section 15<span class="paratitel">Expert knowledge</span></a></td></tr><tr><td colspan="11"><a name="gl_p0497"><!----></a><a href="englisch_amg.html#p0497">Section 16<span class="paratitel">Limitation of the manufacturing authorisation</span></a></td></tr><tr><td colspan="11"><a name="gl_p0499"><!----></a><a href="englisch_amg.html#p0499">Section 17<span class="paratitel">Deadlines for the granting of marketing authorisations</span></a></td></tr><tr><td colspan="11"><a name="gl_p0503"><!----></a><a href="englisch_amg.html#p0503">Section 18<span class="paratitel">Withdrawal, revocation, suspension</span></a></td></tr><tr><td colspan="11"><a name="gl_p0506"><!----></a><a href="englisch_amg.html#p0506">Section 19<span class="paratitel">Areas of responsibility</span></a></td></tr><tr><td colspan="11"><a name="gl_p0508"><!----></a><a href="englisch_amg.html#p0508">Section 20<span class="paratitel">Obligations to notify</span></a></td></tr><tr><td colspan="11"><a name="gl_p0510"><!----></a><a href="englisch_amg.html#p0510">Section 20a<span class="paratitel">Applicability to active substances and other substances</span></a></td></tr><tr><td colspan="11"><a name="gl_p0512"><!----></a><a href="englisch_amg.html#p0512">Section 20b<span class="paratitel">Authorisation for the collection of tissues and the pertinent laboratory tests</span></a></td></tr><tr><td colspan="11"><a name="gl_p0525"><!----></a><a href="englisch_amg.html#p0525">Section 20c<span class="paratitel">Authorisation for the processing, preservation, testing and storage or the placing on the market of tissues or tissue preparations</span></a></td></tr><tr><td colspan="11"><a name="gl_p0540"><!----></a><a href="englisch_amg.html#p0540">Section 20d<span class="paratitel">Exception from the obligation to obtain an authorisation for tissues and tissue preparations</span></a></td></tr><tr><td colspan="11"><a name="gl_p0542"><!----></a><a href="englisch_amg.html#p0542"><strong>Division 4<br />Marketing authorisation of medicinal products</strong></a></td></tr><tr><td colspan="11"><a name="gl_p0543"><!----></a><a href="englisch_amg.html#p0543">Section 21<span class="paratitel">Obligation to obtain a marketing authorisation</span></a></td></tr><tr><td colspan="11"><a name="gl_p0561"><!----></a><a href="englisch_amg.html#p0561">Section 21a<span class="paratitel">Approval of tissue preparations</span></a></td></tr><tr><td colspan="11"><a name="gl_p0600"><!----></a><a href="englisch_amg.html#p0600">Section 22<span class="paratitel">Marketing authorisation documents</span></a></td></tr><tr><td colspan="11"><a name="gl_p0644"><!----></a><a href="englisch_amg.html#p0644">Section 23<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p0645"><!----></a><a href="englisch_amg.html#p0645">Section 24<span class="paratitel">Expert reports</span></a></td></tr><tr><td colspan="11"><a name="gl_p0652"><!----></a><a href="englisch_amg.html#p0652">Section 24a<span class="paratitel">Use of a previous applicant&#8217;s documents</span></a></td></tr><tr><td colspan="11"><a name="gl_p0654"><!----></a><a href="englisch_amg.html#p0654">Section 24b<span class="paratitel">Authorisation of a generic medicinal product, document protection</span></a></td></tr><tr><td colspan="11"><a name="gl_p0661"><!----></a><a href="englisch_amg.html#p0661">Section 24c<span class="paratitel">Additional requests</span></a></td></tr><tr><td colspan="11"><a name="gl_p0663"><!----></a><a href="englisch_amg.html#p0663">Section 24d<span class="paratitel">General right of use</span></a></td></tr><tr><td colspan="11"><a name="gl_p0665"><!----></a><a href="englisch_amg.html#p0665">Section 25<span class="paratitel">Decision on the marketing authorisation</span></a></td></tr><tr><td colspan="11"><a name="gl_p0687"><!----></a><a href="englisch_amg.html#p0687">Section 25a<span class="paratitel">Prior examination</span></a></td></tr><tr><td colspan="11"><a name="gl_p0693"><!----></a><a href="englisch_amg.html#p0693">Section 25b<span class="paratitel">Mutual-recognition procedure and decentralised procedure</span></a></td></tr><tr><td colspan="11"><a name="gl_p0700"><!----></a><a href="englisch_amg.html#p0700">Section 25c<span class="paratitel">Measures taken by the competent higher federal authority on decisions or resolutions of the European Community or the European Union</span></a></td></tr><tr><td colspan="11"><a name="gl_p0702"><!----></a><a href="englisch_amg.html#p0702">Section 26<span class="paratitel">Guidelines for the testing of medicinal products</span></a></td></tr><tr><td colspan="11"><a name="gl_p0705"><!----></a><a href="englisch_amg.html#p0705">Section 27<span class="paratitel">Deadlines for the granting of marketing authorisations</span></a></td></tr><tr><td colspan="11"><a name="gl_p0709"><!----></a><a href="englisch_amg.html#p0709">Section 28 <span class="paratitel">Power to impose conditions</span></a></td></tr><tr><td colspan="11"><a name="gl_p0750"><!----></a><a href="englisch_amg.html#p0750">Section 29<span class="paratitel">Obligation to notify, renewal of the marketing authorisation</span></a></td></tr><tr><td colspan="11"><a name="gl_p0786"><!----></a><a href="englisch_amg.html#p0786">Section 30<span class="paratitel">Withdrawal, revocation, suspension</span></a></td></tr><tr><td colspan="11"><a name="gl_p0804"><!----></a><a href="englisch_amg.html#p0804">Section 31<span class="paratitel">Expiry, extension</span></a></td></tr><tr><td colspan="11"><a name="gl_p0816"><!----></a><a href="englisch_amg.html#p0816">Section 32<span class="paratitel">Official batch testing</span></a></td></tr><tr><td colspan="11"><a name="gl_p0823"><!----></a><a href="englisch_amg.html#p0823">Section 33<span class="paratitel">Reimbursement of expenses and fees</span></a></td></tr><tr><td colspan="11"><a name="gl_p0828"><!----></a><a href="englisch_amg.html#p0828">Section 34<span class="paratitel">Informing the public</span></a></td></tr><tr><td colspan="11"><a name="gl_p0858"><!----></a><a href="englisch_amg.html#p0858">Section 35<span class="paratitel">Empowerments in respect of marketing authorisation and exemptions</span></a></td></tr><tr><td colspan="11"><a name="gl_p0865"><!----></a><a href="englisch_amg.html#p0865">Section 36<span class="paratitel">Empowerment in respect of standard marketing authorisations</span></a></td></tr><tr><td colspan="11"><a name="gl_p0871"><!----></a><a href="englisch_amg.html#p0871">Section 37<span class="paratitel">Authorisation by the European Community or the European Union for placing on the market, marketing authorisation of medicinal products from other states</span></a></td></tr><tr><td colspan="11"><a name="gl_p0874"><!----></a><a href="englisch_amg.html#p0874"><strong>Division 5<br />Registration of medicinal products</strong></a></td></tr><tr><td colspan="11"><a name="gl_p0875"><!----></a><a href="englisch_amg.html#p0875">Section 38<span class="paratitel">Registration of homeopathic medicinal products</span></a></td></tr><tr><td colspan="11"><a name="gl_p0881"><!----></a><a href="englisch_amg.html#p0881">Section 39<span class="paratitel">Decision on the registration of homeopathic medicinal products, procedural provisions</span></a></td></tr><tr><td colspan="11"><a name="gl_p0906"><!----></a><a href="englisch_amg.html#p0906">Section 39a<span class="paratitel">Registration of traditional herbal medicinal products</span></a></td></tr><tr><td colspan="11"><a name="gl_p0908"><!----></a><a href="englisch_amg.html#p0908">Section 39b<span class="paratitel">Registration documents for traditional herbal medicinal products</span></a></td></tr><tr><td colspan="11"><a name="gl_p0920"><!----></a><a href="englisch_amg.html#p0920">Section 39c<span class="paratitel">Decision on the registration of traditional herbal medicinal products</span></a></td></tr><tr><td colspan="11"><a name="gl_p0934"><!----></a><a href="englisch_amg.html#p0934">Section 39d<span class="paratitel">Other procedural provisions for traditional herbal medicinal products</span></a></td></tr><tr><td colspan="11"><a name="gl_p0946"><!----></a><a href="englisch_amg.html#p0946"><strong>Division 6<br />Protection of human subjects in clinical trials</strong></a></td></tr><tr><td colspan="11"><a name="gl_p0947"><!----></a><a href="englisch_amg.html#p0947">Section 40<span class="paratitel">Procedure for authorising clinical trials</span></a></td></tr><tr><td colspan="11"><a name="gl_p0960"><!----></a><a href="englisch_amg.html#p0960">Section 40a<span class="paratitel">General prerequisites for clinical trials</span></a></td></tr><tr><td colspan="11"><a name="gl_p0972"><!----></a><a href="englisch_amg.html#p0972">Section 40b<span class="paratitel">Special prerequisites for clinical trials</span></a></td></tr><tr><td colspan="11"><a name="gl_p0997"><!----></a><a href="englisch_amg.html#p0997">Section 40c<span class="paratitel">Procedure to extend an authorised clinical trial to another Member State, procedure with regard to modifications as well as assessment procedures</span></a></td></tr><tr><td colspan="11"><a name="gl_p1001"><!----></a><a href="englisch_amg.html#p1001">Section 40d<span class="paratitel">Special obligations of the investigator, the sponsor and the competent higher federal authority</span></a></td></tr><tr><td colspan="11"><a name="gl_p1008"><!----></a><a href="englisch_amg.html#p1008">Section 41<span class="paratitel">Ethics committee opinion</span></a></td></tr><tr><td colspan="11"><a name="gl_p1013"><!----></a><a href="englisch_amg.html#p1013">Section 41a<span class="paratitel">Registration process for ethics committees</span></a></td></tr><tr><td colspan="11"><a name="gl_p1027"><!----></a><a href="englisch_amg.html#p1027">Section 41b<span class="paratitel">Rules of procedure and schedule of responsibilities</span></a></td></tr><tr><td colspan="11"><a name="gl_p1034"><!----></a><a href="englisch_amg.html#p1034">Section 41c<span class="paratitel">Specialised ethics committee for specific procedures</span></a></td></tr><tr><td colspan="11"><a name="gl_p1046"><!----></a><a href="englisch_amg.html#p1046">Section 41d<span class="paratitel">Guidelines for assessing clinical trials by ethics committees</span></a></td></tr><tr><td colspan="11"><a name="gl_p1050"><!----></a><a href="englisch_amg.html#p1050">Section 42<span class="paratitel">Corrective measures</span></a></td></tr><tr><td colspan="11"><a name="gl_p1059"><!----></a><a href="englisch_amg.html#p1059">Section 42a<span class="paratitel">Data protection</span></a></td></tr><tr><td colspan="11"><a name="gl_p1061"><!----></a><a href="englisch_amg.html#p1061">Section 42b<span class="paratitel">Publication of the results of clinical trials</span></a></td></tr><tr><td colspan="11"><a name="gl_p1064"><!----></a><a href="englisch_amg.html#p1064">Section 42c<span class="paratitel">Inspections</span></a></td></tr><tr><td colspan="11"><a name="gl_p1074"><!----></a><a href="englisch_amg.html#p1074">Section 42d<span class="paratitel">Standard contractual clauses for the performance of clinical trials</span></a></td></tr><tr><td colspan="11"><a name="gl_p1088"><!----></a><a href="englisch_amg.html#p1088">Section 42e<span class="paratitel">Recommendations for clinical trials performed by non-commercial sponsors without commercial intent</span></a></td></tr><tr><td colspan="11"><a name="gl_p1091"><!----></a><a href="englisch_amg.html#p1091"><strong>Division 7<br />Sale of medicinal products</strong></a></td></tr><tr><td colspan="11"><a name="gl_p1092"><!----></a><a href="englisch_amg.html#p1092">Section 43<span class="paratitel">Pharmacy-only requirement</span></a></td></tr><tr><td colspan="11"><a name="gl_p1097"><!----></a><a href="englisch_amg.html#p1097">Section 44<span class="paratitel">Exceptions to the pharmacy-only requirement</span></a></td></tr><tr><td colspan="11"><a name="gl_p1114"><!----></a><a href="englisch_amg.html#p1114">Section 45<span class="paratitel">Authority to allow further exceptions to the pharmacy-only requirement</span></a></td></tr><tr><td colspan="11"><a name="gl_p1122"><!----></a><a href="englisch_amg.html#p1122">Section 46<span class="paratitel">Authority to extend the pharmacy-only requirement</span></a></td></tr><tr><td colspan="11"><a name="gl_p1126"><!----></a><a href="englisch_amg.html#p1126">Section 47<span class="paratitel">Distribution channel</span></a></td></tr><tr><td colspan="11"><a name="gl_p1161"><!----></a><a href="englisch_amg.html#p1161">Section 47a<span class="paratitel">Special distribution channels, obligation to keep records</span></a></td></tr><tr><td colspan="11"><a name="gl_p1166"><!----></a><a href="englisch_amg.html#p1166">Section 47b<span class="paratitel">Special distribution channels, diamorphine</span></a></td></tr><tr><td colspan="11"><a name="gl_p1169"><!----></a><a href="englisch_amg.html#p1169">Section 48<span class="paratitel">Prescription requirement</span></a></td></tr><tr><td colspan="11"><a name="gl_p1197"><!----></a><a href="englisch_amg.html#p1197">Section 49<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p1198"><!----></a><a href="englisch_amg.html#p1198">Section 50<span class="paratitel">Retail trading of over-the-counter medicinal products</span></a></td></tr><tr><td colspan="11"><a name="gl_p1207"><!----></a><a href="englisch_amg.html#p1207">Section 51<span class="paratitel">Sale by itinerant traders</span></a></td></tr><tr><td colspan="11"><a name="gl_p1212"><!----></a><a href="englisch_amg.html#p1212">Section 52<span class="paratitel">Prohibition of self-service</span></a></td></tr><tr><td colspan="11"><a name="gl_p1221"><!----></a><a href="englisch_amg.html#p1221">Section 52a<span class="paratitel">Wholesale trading of medicinal products</span></a></td></tr><tr><td colspan="11"><a name="gl_p1237"><!----></a><a href="englisch_amg.html#p1237">Section 52b<span class="paratitel">Supply of medicinal products</span></a></td></tr><tr><td colspan="11"><a name="gl_p1262"><!----></a><a href="englisch_amg.html#p1262">Section 52c<span class="paratitel">Brokering of medicinal products</span></a></td></tr><tr><td colspan="11"><a name="gl_p1266"><!----></a><a href="englisch_amg.html#p1266">Section 53<span class="paratitel">Expert consultation</span></a></td></tr><tr><td colspan="11"><a name="gl_p1269"><!----></a><a href="englisch_amg.html#p1269"><strong>Division 8<br />Safety and quality control</strong></a></td></tr><tr><td colspan="11"><a name="gl_p1270"><!----></a><a href="englisch_amg.html#p1270">Section 54<span class="paratitel">Internal regulations</span></a></td></tr><tr><td colspan="11"><a name="gl_p1287"><!----></a><a href="englisch_amg.html#p1287">Section 55<span class="paratitel">Pharmacopoeia</span></a></td></tr><tr><td colspan="11"><a name="gl_p1297"><!----></a><a href="englisch_amg.html#p1297">Section 55a<span class="paratitel">Official compilation of test procedures</span></a></td></tr><tr><td colspan="11"><a name="gl_p1299"><!----></a><a href="englisch_amg.html#p1299"><strong>Division 9<br />(repealed)</strong></a></td></tr><tr><td colspan="11"><a name="gl_p1300"><!----></a><a href="englisch_amg.html#p1300"><strong>Division 10<br />Monitoring, compiling and evaluating the risks of medicinal products</strong></a></td></tr><tr><td colspan="11"><a name="gl_p1301"><!----></a><a href="englisch_amg.html#p1301">Section 62<span class="paratitel">Organisation</span></a></td></tr><tr><td colspan="11"><a name="gl_p1311"><!----></a><a href="englisch_amg.html#p1311">Section 63<span class="paratitel">Graduated plan</span></a></td></tr><tr><td colspan="11"><a name="gl_p1313"><!----></a><a href="englisch_amg.html#p1313">Section 63a<span class="paratitel">Graduated plan officer</span></a></td></tr><tr><td colspan="11"><a name="gl_p1317"><!----></a><a href="englisch_amg.html#p1317">Section 63b<span class="paratitel">General pharmacovigilance obligations of the marketing authorisation holder</span></a></td></tr><tr><td colspan="11"><a name="gl_p1327"><!----></a><a href="englisch_amg.html#p1327">Section 63c<span class="paratitel">Documentation and reporting obligations of the holder of a marketing authorisation in the case of suspected adverse reactions</span></a></td></tr><tr><td colspan="11"><a name="gl_p1343"><!----></a><a href="englisch_amg.html#p1343">Section 63d<span class="paratitel">Periodic safety update reports</span></a></td></tr><tr><td colspan="11"><a name="gl_p1363"><!----></a><a href="englisch_amg.html#p1363">Section 63e<span class="paratitel">European procedure</span></a></td></tr><tr><td colspan="11"><a name="gl_p1365"><!----></a><a href="englisch_amg.html#p1365">Section 63f<span class="paratitel">General prerequisites for non-interventional post-authorisation safety studies</span></a></td></tr><tr><td colspan="11"><a name="gl_p1373"><!----></a><a href="englisch_amg.html#p1373">Section 63g<span class="paratitel">Special prerequisites for imposed non-interventional post-authorisation safety studies</span></a></td></tr><tr><td colspan="11"><a name="gl_p1386"><!----></a><a href="englisch_amg.html#p1386">Section 63h<span class="paratitel">(repealed)</span></a></td></tr><tr><td colspan="11"><a name="gl_p1387"><!----></a><a href="englisch_amg.html#p1387">Section 63i<span class="paratitel">Documentation and notification obligations in respect of blood and tissue preparations and tissues</span></a></td></tr><tr><td colspan="11"><a name="gl_p1396"><!----></a><a href="englisch_amg.html#p1396">Section 63j<span class="paratitel">Documentation and notification obligations on the part of the person conducting treatment, in respect of advanced therapy medicinal products that require neither a marketing authorisation nor approval</span></a></td></tr><tr><td colspan="11"><a name="gl_p1408"><!----></a><a href="englisch_amg.html#p1408">Section 63k<span class="paratitel">Exceptions</span></a></td></tr><tr><td colspan="11"><a name="gl_p1410"><!----></a><a href="englisch_amg.html#p1410"><strong>Division 11<br />Surveillance</strong></a></td></tr><tr><td colspan="11"><a name="gl_p1411"><!----></a><a href="englisch_amg.html#p1411">Section 64<span class="paratitel">Conducting supervision</span></a></td></tr><tr><td colspan="11"><a name="gl_p1447"><!----></a><a href="englisch_amg.html#p1447">Section 65<span class="paratitel">Sampling</span></a></td></tr><tr><td colspan="11"><a name="gl_p1455"><!----></a><a href="englisch_amg.html#p1455">Section 66<span class="paratitel">Obligation to tolerate and collaborate</span></a></td></tr><tr><td colspan="11"><a name="gl_p1458"><!----></a><a href="englisch_amg.html#p1458">Section 67<span class="paratitel">General notification requirement</span></a></td></tr><tr><td colspan="11"><a name="gl_p1480"><!----></a><a href="englisch_amg.html#p1480">Section 67a<span class="paratitel">Database-supported information system</span></a></td></tr><tr><td colspan="11"><a name="gl_p1489"><!----></a><a href="englisch_amg.html#p1489">Section 67b<span class="paratitel">EU Compendium of Tissue Establishments, EU Compendium of Tissue and Cell Products, obligations to inform</span></a></td></tr><tr><td colspan="11"><a name="gl_p1505"><!----></a><a href="englisch_amg.html#p1505">Section 68<span class="paratitel">Obligations to notify and to inform</span></a></td></tr><tr><td colspan="11"><a name="gl_p1518"><!----></a><a href="englisch_amg.html#p1518">Section 69<span class="paratitel">Measures by the competent authorities</span></a></td></tr><tr><td colspan="11"><a name="gl_p1542"><!----></a><a href="englisch_amg.html#p1542">Section 69a<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p1543"><!----></a><a href="englisch_amg.html#p1543">Section 69b<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p1544"><!----></a><a href="englisch_amg.html#p1544"><strong>Division 12<br />Special provisions for the Federal Armed Forces, Federal Police, Public Order Police, Civil Protection</strong></a></td></tr><tr><td colspan="11"><a name="gl_p1545"><!----></a><a href="englisch_amg.html#p1545">Section 70<span class="paratitel">Application and enforcement of the Act</span></a></td></tr><tr><td colspan="11"><a name="gl_p1548"><!----></a><a href="englisch_amg.html#p1548">Section 71<span class="paratitel">Exceptions</span></a></td></tr><tr><td colspan="11"><a name="gl_p1552"><!----></a><a href="englisch_amg.html#p1552"><strong>Division 13<br />Import and export</strong></a></td></tr><tr><td colspan="11"><a name="gl_p1553"><!----></a><a href="englisch_amg.html#p1553">Section 72<span class="paratitel">Import authorisation</span></a></td></tr><tr><td colspan="11"><a name="gl_p1568"><!----></a><a href="englisch_amg.html#p1568">Section 72a<span class="paratitel">Certificates</span></a></td></tr><tr><td colspan="11"><a name="gl_p1595"><!----></a><a href="englisch_amg.html#p1595">Section 72b<span class="paratitel">Import authorisations and certificates for tissues and specific tissue preparations</span></a></td></tr><tr><td colspan="11"><a name="gl_p1620"><!----></a><a href="englisch_amg.html#p1620">Section 72c<span class="paratitel">One-off import of tissues and tissue preparations</span></a></td></tr><tr><td colspan="11"><a name="gl_p1625"><!----></a><a href="englisch_amg.html#p1625">Section 73<span class="paratitel">Prohibition of introduction</span></a></td></tr><tr><td colspan="11"><a name="gl_p1663"><!----></a><a href="englisch_amg.html#p1663">Section 73a<span class="paratitel">Export</span></a></td></tr><tr><td colspan="11"><a name="gl_p1666"><!----></a><a href="englisch_amg.html#p1666">Section 74<span class="paratitel">Participation of customs offices</span></a></td></tr><tr><td colspan="11"><a name="gl_p1673"><!----></a><a href="englisch_amg.html#p1673"><strong>Division 14<br />Information officer, pharmaceutical consultant</strong></a></td></tr><tr><td colspan="11"><a name="gl_p1674"><!----></a><a href="englisch_amg.html#p1674">Section 74a<span class="paratitel">Information officer</span></a></td></tr><tr><td colspan="11"><a name="gl_p1678"><!----></a><a href="englisch_amg.html#p1678">Section 75<span class="paratitel">Expert knowledge</span></a></td></tr><tr><td colspan="11"><a name="gl_p1685"><!----></a><a href="englisch_amg.html#p1685">Section 76<span class="paratitel">Duties</span></a></td></tr><tr><td colspan="11"><a name="gl_p1688"><!----></a><a href="englisch_amg.html#p1688"><strong>Division 15<br />Designation of the competent higher federal authorities and other provisions</strong></a></td></tr><tr><td colspan="11"><a name="gl_p1689"><!----></a><a href="englisch_amg.html#p1689">Section 77<span class="paratitel">Competent higher federal authority; power to issue ordinances</span></a></td></tr><tr><td colspan="11"><a name="gl_p1698"><!----></a><a href="englisch_amg.html#p1698">Section 77a<span class="paratitel">Independence and transparency</span></a></td></tr><tr><td colspan="11"><a name="gl_p1701"><!----></a><a href="englisch_amg.html#p1701">Section 78<span class="paratitel">Prices</span></a></td></tr><tr><td colspan="11"><a name="gl_p1711"><!----></a><a href="englisch_amg.html#p1711">Section 79<span class="paratitel">Authority to permit exceptions in times of crisis</span></a></td></tr><tr><td colspan="11"><a name="gl_p1723"><!----></a><a href="englisch_amg.html#p1723">Section 80<span class="paratitel">Authority to issue procedural and compassionate use regulations</span></a></td></tr><tr><td colspan="11"><a name="gl_p1739"><!----></a><a href="englisch_amg.html#p1739">Section 81<span class="paratitel">Relation to other laws</span></a></td></tr><tr><td colspan="11"><a name="gl_p1741"><!----></a><a href="englisch_amg.html#p1741">Section 82<span class="paratitel">General administrative regulations</span></a></td></tr><tr><td colspan="11"><a name="gl_p1743"><!----></a><a href="englisch_amg.html#p1743">Section 83<span class="paratitel">Approximation to European Union legislation</span></a></td></tr><tr><td colspan="11"><a name="gl_p1745"><!----></a><a href="englisch_amg.html#p1745">Section 83a<span class="paratitel">Ordinances for specific cases</span></a></td></tr><tr><td colspan="11"><a name="gl_p1747"><!----></a><a href="englisch_amg.html#p1747"><strong>Division 16<br />Liability for damages caused by medicinal products</strong></a></td></tr><tr><td colspan="11"><a name="gl_p1748"><!----></a><a href="englisch_amg.html#p1748">Section 84<span class="paratitel">Absolute liability</span></a></td></tr><tr><td colspan="11"><a name="gl_p1754"><!----></a><a href="englisch_amg.html#p1754">Section 84a<span class="paratitel">Right to disclosure</span></a></td></tr><tr><td colspan="11"><a name="gl_p1757"><!----></a><a href="englisch_amg.html#p1757">Section 85<span class="paratitel">Contributory negligence</span></a></td></tr><tr><td colspan="11"><a name="gl_p1759"><!----></a><a href="englisch_amg.html#p1759">Section 86<span class="paratitel">Extent of liability for damages in the case of death</span></a></td></tr><tr><td colspan="11"><a name="gl_p1763"><!----></a><a href="englisch_amg.html#p1763">Section 87<span class="paratitel">Extent of liability for damages in the case of bodily injury</span></a></td></tr><tr><td colspan="11"><a name="gl_p1765"><!----></a><a href="englisch_amg.html#p1765">Section 88<span class="paratitel">Maximum amounts</span></a></td></tr><tr><td colspan="11"><a name="gl_p1770"><!----></a><a href="englisch_amg.html#p1770">Section 89<span class="paratitel">Compensation in the form of annuities</span></a></td></tr><tr><td colspan="11"><a name="gl_p1774"><!----></a><a href="englisch_amg.html#p1774">Section 90<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p1775"><!----></a><a href="englisch_amg.html#p1775">Section 91<span class="paratitel">Extended liability</span></a></td></tr><tr><td colspan="11"><a name="gl_p1777"><!----></a><a href="englisch_amg.html#p1777">Section 92<span class="paratitel">Mandatory provision</span></a></td></tr><tr><td colspan="11"><a name="gl_p1779"><!----></a><a href="englisch_amg.html#p1779">Section 93<span class="paratitel">Several parties liable for damages</span></a></td></tr><tr><td colspan="11"><a name="gl_p1781"><!----></a><a href="englisch_amg.html#p1781">Section 94<span class="paratitel">Coverage provision</span></a></td></tr><tr><td colspan="11"><a name="gl_p1789"><!----></a><a href="englisch_amg.html#p1789">Section 94a<span class="paratitel">Local jurisdiction</span></a></td></tr><tr><td colspan="11"><a name="gl_p1792"><!----></a><a href="englisch_amg.html#p1792"><strong>Division 17<br />Penal provisions and provisions on administrative fines</strong></a></td></tr><tr><td colspan="11"><a name="gl_p1793"><!----></a><a href="englisch_amg.html#p1793">Section 95<span class="paratitel">Penal provisions</span></a></td></tr><tr><td colspan="11"><a name="gl_p1812"><!----></a><a href="englisch_amg.html#p1812">Section 96<span class="paratitel">Penal provisions</span></a></td></tr><tr><td colspan="11"><a name="gl_p1842"><!----></a><a href="englisch_amg.html#p1842">Section 97<span class="paratitel">Provisions on administrative fines</span></a></td></tr><tr><td colspan="11"><a name="gl_p1934"><!----></a><a href="englisch_amg.html#p1934">Section 98<span class="paratitel">Confiscation</span></a></td></tr><tr><td colspan="11"><a name="gl_p1936"><!----></a><a href="englisch_amg.html#p1936">Section 98a<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p1937"><!----></a><a href="englisch_amg.html#p1937"><strong>Division 18<br />Transitional provisions</strong></a></td></tr><tr><td colspan="11"><a name="gl_p1938"><!----></a><a href="englisch_amg.html#p1938"><strong>Subdivision 1<br />Transitional provisions arising out of the Law on the Reform of Drug Legislation</strong></a></td></tr><tr><td colspan="11"><a name="gl_p1939"><!----></a><a href="englisch_amg.html#p1939">Section 99<span class="paratitel">1961 Drug Law</span></a></td></tr><tr><td colspan="11"><a name="gl_p1941"><!----></a><a href="englisch_amg.html#p1941">Section 100</a></td></tr><tr><td colspan="11"><a name="gl_p1945"><!----></a><a href="englisch_amg.html#p1945">Section 101<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p1946"><!----></a><a href="englisch_amg.html#p1946">Section 102</a></td></tr><tr><td colspan="11"><a name="gl_p1951"><!----></a><a href="englisch_amg.html#p1951">Section 102a<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p1952"><!----></a><a href="englisch_amg.html#p1952">Section 103</a></td></tr><tr><td colspan="11"><a name="gl_p1955"><!----></a><a href="englisch_amg.html#p1955">Section 104<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p1956"><!----></a><a href="englisch_amg.html#p1956">Section 105</a></td></tr><tr><td colspan="11"><a name="gl_p1985"><!----></a><a href="englisch_amg.html#p1985">Section 105a</a></td></tr><tr><td colspan="11"><a name="gl_p1990"><!----></a><a href="englisch_amg.html#p1990">Section 105b<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p1991"><!----></a><a href="englisch_amg.html#p1991">Section 106<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p1992"><!----></a><a href="englisch_amg.html#p1992">Section 107<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p1993"><!----></a><a href="englisch_amg.html#p1993">Section 108<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p1994"><!----></a><a href="englisch_amg.html#p1994">Section 108a</a></td></tr><tr><td colspan="11"><a name="gl_p1996"><!----></a><a href="englisch_amg.html#p1996">Section 108b<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p1997"><!----></a><a href="englisch_amg.html#p1997">Section 109</a></td></tr><tr><td colspan="11"><a name="gl_p2008"><!----></a><a href="englisch_amg.html#p2008">Section 109a</a></td></tr><tr><td colspan="11"><a name="gl_p2014"><!----></a><a href="englisch_amg.html#p2014">Section 110</a></td></tr><tr><td colspan="11"><a name="gl_p2016"><!----></a><a href="englisch_amg.html#p2016">Section 111<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p2017"><!----></a><a href="englisch_amg.html#p2017">Section 112</a></td></tr><tr><td colspan="11"><a name="gl_p2019"><!----></a><a href="englisch_amg.html#p2019">Section 113<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p2020"><!----></a><a href="englisch_amg.html#p2020">Section 114<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p2021"><!----></a><a href="englisch_amg.html#p2021">Section 115</a></td></tr><tr><td colspan="11"><a name="gl_p2023"><!----></a><a href="englisch_amg.html#p2023">Section 116</a></td></tr><tr><td colspan="11"><a name="gl_p2025"><!----></a><a href="englisch_amg.html#p2025">Section 117<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p2026"><!----></a><a href="englisch_amg.html#p2026">Section 118</a></td></tr><tr><td colspan="11"><a name="gl_p2028"><!----></a><a href="englisch_amg.html#p2028">Section 119</a></td></tr><tr><td colspan="11"><a name="gl_p2030"><!----></a><a href="englisch_amg.html#p2030">Section 120</a></td></tr><tr><td colspan="11"><a name="gl_p2032"><!----></a><a href="englisch_amg.html#p2032">Section 121<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p2033"><!----></a><a href="englisch_amg.html#p2033">Section 122</a></td></tr><tr><td colspan="11"><a name="gl_p2035"><!----></a><a href="englisch_amg.html#p2035">Section 123</a></td></tr><tr><td colspan="11"><a name="gl_p2037"><!----></a><a href="englisch_amg.html#p2037">Section 124</a></td></tr><tr><td colspan="11"><a name="gl_p2039"><!----></a><a href="englisch_amg.html#p2039"><strong>Subdivision 2</strong></a></td></tr><tr><td colspan="11"><a name="gl_p2040"><!----></a><a href="englisch_amg.html#p2040">Section 125<span class="paratitel">(repealed)</span></a></td></tr><tr><td colspan="11"><a name="gl_p2041"><!----></a><a href="englisch_amg.html#p2041">Section 126</a></td></tr><tr><td colspan="11"><a name="gl_p2043"><!----></a><a href="englisch_amg.html#p2043"><strong>Subdivision 3<br />Transitional provisions arising out of the Second Act Amending the Drug Law (Act on Medicinal Products)</strong></a></td></tr><tr><td colspan="11"><a name="gl_p2044"><!----></a><a href="englisch_amg.html#p2044">Section 127</a></td></tr><tr><td colspan="11"><a name="gl_p2047"><!----></a><a href="englisch_amg.html#p2047">Section 128</a></td></tr><tr><td colspan="11"><a name="gl_p2050"><!----></a><a href="englisch_amg.html#p2050">Section 129</a></td></tr><tr><td colspan="11"><a name="gl_p2052"><!----></a><a href="englisch_amg.html#p2052">Section 130</a></td></tr><tr><td colspan="11"><a name="gl_p2054"><!----></a><a href="englisch_amg.html#p2054">Section 131</a></td></tr><tr><td colspan="11"><a name="gl_p2056"><!----></a><a href="englisch_amg.html#p2056"><strong>Subdivision 4<br />Transitional provisions arising out of the Fifth Act Amending the Drug Law (Act on Medicinal Products)</strong></a></td></tr><tr><td colspan="11"><a name="gl_p2057"><!----></a><a href="englisch_amg.html#p2057">Section 132</a></td></tr><tr><td colspan="11"><a name="gl_p2064"><!----></a><a href="englisch_amg.html#p2064"><strong>Subdivision 5<br />Transitional provision arising of the Seventh Act Amending the Drug Law</strong></a></td></tr><tr><td colspan="11"><a name="gl_p2065"><!----></a><a href="englisch_amg.html#p2065">Section 133<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p2066"><!----></a><a href="englisch_amg.html#p2066"><strong>Subdivision 6<br />Transitional provisions arising out of the Transfusion Act</strong></a></td></tr><tr><td colspan="11"><a name="gl_p2067"><!----></a><a href="englisch_amg.html#p2067">Section 134</a></td></tr><tr><td colspan="11"><a name="gl_p2069"><!----></a><a href="englisch_amg.html#p2069"><strong>Subdivision 7<br />Transitional provisions arising out of the Eighth Act Amending the Drug Law (Act on Medicinal Products)</strong></a></td></tr><tr><td colspan="11"><a name="gl_p2070"><!----></a><a href="englisch_amg.html#p2070">Section 135</a></td></tr><tr><td colspan="11"><a name="gl_p2075"><!----></a><a href="englisch_amg.html#p2075"><strong>Subdivision 8<br />Transitional provisions arising out of the Tenth Act Amending the Drug Law (Act on Medicinal Products)</strong></a></td></tr><tr><td colspan="11"><a name="gl_p2076"><!----></a><a href="englisch_amg.html#p2076">Section 136</a></td></tr><tr><td colspan="11"><a name="gl_p2082"><!----></a><a href="englisch_amg.html#p2082"><strong>Subdivision 9<br />Transitional provisions arising out of the Eleventh Act Amending the Drug Law (Act on Medicinal Products)</strong></a></td></tr><tr><td colspan="11"><a name="gl_p2083"><!----></a><a href="englisch_amg.html#p2083">Section 137<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p2084"><!----></a><a href="englisch_amg.html#p2084"><strong>Subdivision 10<br />Transitional provisions arising out of the Twelfth Act Amending the Act on Medicinal Products</strong></a></td></tr><tr><td colspan="11"><a name="gl_p2085"><!----></a><a href="englisch_amg.html#p2085">Section 138</a></td></tr><tr><td colspan="11"><a name="gl_p2093"><!----></a><a href="englisch_amg.html#p2093"><strong>Subdivision 11<br />Transitional provisions arising out of the First Act Amending the Transfusion Act and the Regulations on Medicinal Products</strong></a></td></tr><tr><td colspan="11"><a name="gl_p2094"><!----></a><a href="englisch_amg.html#p2094">Section 139</a></td></tr><tr><td colspan="11"><a name="gl_p2096"><!----></a><a href="englisch_amg.html#p2096"><strong>Subdivision 12<br />Transitional provisions arising out of the Thirteenth Act Amending the Act on Medicinal Products</strong></a></td></tr><tr><td colspan="11"><a name="gl_p2097"><!----></a><a href="englisch_amg.html#p2097">Section 140<span class="paratitel">(no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p2098"><!----></a><a href="englisch_amg.html#p2098"><strong>Subdivision 13<br />Transitional provisions arising out of the Fourteenth Act Amending the Act on Medicinal Products</strong></a></td></tr><tr><td colspan="11"><a name="gl_p2099"><!----></a><a href="englisch_amg.html#p2099">Section 141</a></td></tr><tr><td colspan="11"><a name="gl_p2114"><!----></a><a href="englisch_amg.html#p2114"><strong>Subdivision 14</strong></a></td></tr><tr><td colspan="11"><a name="gl_p2115"><!----></a><a href="englisch_amg.html#p2115">Section 142<span class="paratitel">Transitional provisions arising out of the Tissues Act</span></a></td></tr><tr><td colspan="11"><a name="gl_p2119"><!----></a><a href="englisch_amg.html#p2119">Section 142a<span class="paratitel">Transitional provision and grandfathering provision arising out of the Act Implementing Commission Directive (EU) 2015/566 and (EU) 2015/565 on the import and coding of human tissue and tissue products</span></a></td></tr><tr><td colspan="11"><a name="gl_p2123"><!----></a><a href="englisch_amg.html#p2123">Section 142b<span class="paratitel">Transitional provisions arising out of the Act Updating the Regulations governing Blood and Tissue Preparations and Amending Additional Provisions</span></a></td></tr><tr><td colspan="11"><a name="gl_p2126"><!----></a><a href="englisch_amg.html#p2126"><strong>Subdivision 15</strong></a></td></tr><tr><td colspan="11"><a name="gl_p2127"><!----></a><a href="englisch_amg.html#p2127">Section 143<span class="paratitel">Transitional provisions arising out of the Act on improving measures against doping in sport (no longer applicable)</span></a></td></tr><tr><td colspan="11"><a name="gl_p2128"><!----></a><a href="englisch_amg.html#p2128"><strong>Subdivision 16</strong></a></td></tr><tr><td colspan="11"><a name="gl_p2129"><!----></a><a href="englisch_amg.html#p2129">Section 144<span class="paratitel">Transitional provisions arising out of the Act amending the regulations on medicinal products and other regulations</span></a></td></tr><tr><td colspan="11"><a name="gl_p2137"><!----></a><a href="englisch_amg.html#p2137"><strong>Subdivision 17</strong></a></td></tr><tr><td colspan="11"><a name="gl_p2138"><!----></a><a href="englisch_amg.html#p2138">Section 145<span class="paratitel">Transitional provisions arising out of the Act on the Reform of the Market for Medicinal Products</span></a></td></tr><tr><td colspan="11"><a name="gl_p2140"><!----></a><a href="englisch_amg.html#p2140"><strong>Subdivision 18<br />Transitional provision</strong></a></td></tr><tr><td colspan="11"><a name="gl_p2141"><!----></a><a href="englisch_amg.html#p2141">Section 146<span class="paratitel">Transitional provisions arising out of the Second Act amending regulations on medicinal products and other regulations</span></a></td></tr><tr><td colspan="11"><a name="gl_p2155"><!----></a><a href="englisch_amg.html#p2155"><strong>Subdivision 19<br />Transitional provision</strong></a></td></tr><tr><td colspan="11"><a name="gl_p2156"><!----></a><a href="englisch_amg.html#p2156">Section 147<span class="paratitel">Transitional provision arising out of the Third Act amending the regulations pertaining to medicinal products and other regulations</span></a></td></tr><tr><td colspan="11"><a name="gl_p2158"><!----></a><a href="englisch_amg.html#p2158"><strong>Subdivision 20<br />Transitional provision</strong></a></td></tr><tr><td colspan="11"><a name="gl_p2159"><!----></a><a href="englisch_amg.html#p2159">Section 148<span class="paratitel">Transitional provision arising out of the Fourth Act amending regulations pertaining to medicinal products and other regulations, as well as the Act enacting a Veterinary Medicinal Products Act and adapting regulations pertaining to medicinal products and other regulations</span></a></td></tr><tr><td colspan="11"><a name="gl_p2163"><!----></a><a href="englisch_amg.html#p2163"><strong>Annex:<br />(to section 6)</strong></a></td></tr></table></div></div><div id="fusszeile"><ul class="footerul"><li><a accesskey="1" class="navBlack" href="#Seitenanfang">zum Seitenanfang</a></li><li><a accesskey="6" class="navBlack" href="https://www.gesetze-im-internet.de/impressum.html" title="Impressum">Impressum</a></li><li><a accesskey="8" class="navBlack" href="https://www.gesetze-im-internet.de/datenschutz.html" title="Datenschutz">Datenschutz</a></li><li><a class="navBlack" href="https://www.gesetze-im-internet.de/barrierefreiheit.html" title="Erklärung zur Barrierefreiheit">Barrierefreiheitserklärung</a></li><li><a class="navBlack" href="https://www.gesetze-im-internet.de/feedbackformular.html" title="Barriere melden">Feedback-Formular</a></li><li><script type="text/javascript"><!-- // /* <![CDATA[ */
document.write("<div id='relRechts'><a href='javascript:window.print()' class='navBlack'>Seite ausdrucken</a></div>");
/* ]]> */ //--></script><noscript><!----></noscript></li></ul></div></div></div></body></html>